Ascendant Digital Acquisition Corp III (ACDI) 10-Q 14 Nov 22 2022 Q3 Quarterly report Financial data

Cover Page

Cover Page - shares	9 Months Ended
	Sep. 30, 2022	Nov. 14, 2022
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Amendment Flag	false
Document Period End Date	Sep. 30, 2022
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Entity Registrant Name	ASCENDANT DIGITAL ACQUISITION CORP. III
Entity Central Index Key	0001850316
Entity File Number	001-41036
Entity Filer Category	Non-accelerated Filer
Entity Tax Identification Number	00-0000000
Entity Incorporation, State or Country Code	E9
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Shell Company	true
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Address, Address Line One	667 Madison Avenue
Entity Address, Address Line Two	5th Floor
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10065
City Area Code	212
Local Phone Number	209-6126
Title of 12(b) Security	Class A ordinary shares, par value $0.0001 per share
Trading Symbol	ACDI
Security Exchange Name	NYSE
Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-half of one redeemable warrant [Member]
Document Information [Line Items]
Title of 12(b) Security	Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-half of one redeemable warrant
Trading Symbol	ACDI.U
Security Exchange Name	NYSE
Redeemable warrants, each warrant exercisable for one Class A ordinary share, each at an exercise price of $11.50 per share [Member]
Document Information [Line Items]
Title of 12(b) Security	Redeemable warrants, each warrant exercisable for one Class A ordinary share, each at an exercise price of $11.50 per share
Trading Symbol	ACDI WS
Security Exchange Name	NYSE
Common Class A [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		30,000,000
Common Class B [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		7,500,000

CONDENSED BALANCE SHEETS

CONDENSED BALANCE SHEETS - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Current assets:
Cash	$ 456,029	$ 831,432
Prepaid expenses	593,811	970,696
Total current assets	1,049,840	1,802,128
Investments held in Trust Account	308,042,301	306,016,692
Total Assets	309,092,141	307,818,820
Current liabilities:
Accounts payable	215,366	27,416
Accounts payable - related party		18,898
Accrued expenses	121,688	119,732
Total current liabilities	337,054	166,046
Derivative warrant liabilities	1,325,000	18,285,000
Deferred underwriting commissions	10,500,000	10,500,000
Total liabilities	12,162,054	28,951,046
Commitments and Contingencies
Class A ordinary shares subject to possible redemption, $0.0001 par value, 30,000,000 shares at redemption value of approximately $10.26 and $10.20 per share as of September 30, 2022 and December 31, 2021, respectively	307,942,301	306,000,000
Shareholders' Deficit:
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued or outstanding	0	0
Additional paid-in capital	0	0
Accumulated deficit	(11,012,964)	(27,132,976)
Total shareholders' deficit	(11,012,214)	(27,132,226)
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit	309,092,141	307,818,820
Common Class A [Member]
Current liabilities:
Class A ordinary shares subject to possible redemption, $0.0001 par value, 30,000,000 shares at redemption value of approximately $10.26 and $10.20 per share as of September 30, 2022 and December 31, 2021, respectively	307,942,301	306,000,000
Shareholders' Deficit:
Common Stock, Value, Issued	0	0
Common Class B [Member]
Shareholders' Deficit:
Common Stock, Value, Issued	$ 750	$ 750

CONDENSED BALANCE SHEETS (Paren

CONDENSED BALANCE SHEETS (Parenthetical) - $ / shares	Sep. 30, 2022	Dec. 31, 2021
Preferred stock par or stated value per share	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common Class A [Member]
Common stock par or stated value per share	$ 0.0001	$ 0.0001
Common stock shares authorized	500,000,000	500,000,000
Common stock shares issued	0	0
Common stock shares outstanding	0	0
Temporary equity, par or stated value per share	$ 0.0001	$ 0.0001
Temporary equity, shares issued	30,000,000	30,000,000
Temporary equity, redemption price per share	$ 10.26	$ 10.2
Common Class B [Member]
Common stock par or stated value per share	$ 0.0001	$ 0.0001
Common stock shares authorized	50,000,000	50,000,000
Common stock shares issued	7,500,000	7,500,000
Common stock shares outstanding	7,500,000	7,500,000

UNAUDITED CONDENSED STATEMENTS

UNAUDITED CONDENSED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		7 Months Ended	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2021	Sep. 30, 2022
General and administrative expenses	$ 321,278		$ 10,243	$ 833,394
Administrative expenses - related party	30,000			90,000
Loss from operations	(351,278)		(10,243)	(923,394)
Other income:
Change in fair value of derivative warrant liabilities	2,120,000	0	0	16,960,000
Interest income from operating account	61			98
Income from investments held in Trust Account	1,475,383		0	2,025,609
Total other income	3,595,444			18,985,707
Net income (loss)	3,244,166		$ (10,243)	18,062,313
Common Class A [Member]
Other income:
Net income (loss)	$ 2,595,333	$ 0		$ 14,449,850
Basic weighted average shares outstanding	30,000,000	0	0	30,000,000
Diluted weighted average shares outstanding	30,000,000	0		30,000,000
Basic net income per ordinary share	$ 0.09	$ 0	$ 0	$ 0.48
Diluted net income per ordinary share	$ 0.09	$ 0		$ 0.48
Common Class B [Member]
Other income:
Net income (loss)	$ 648,833	$ 0		$ 3,612,463
Basic weighted average shares outstanding	7,500,000	6,525,000	6,525,000	7,500,000
Diluted weighted average shares outstanding	7,500,000	6,525,000	6,525,000	7,500,000
Basic net income per ordinary share	$ 0.09	$ 0	$ 0	$ 0.48
Diluted net income per ordinary share	$ 0.09	$ 0	$ 0	$ 0.48

UNAUDITED CONDENSED STATEMENT_2

UNAUDITED CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT - USD ($)	Total	Common Class B [Member]	Common Stock [Member] Common Class B [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]
Beginning Balance at Feb. 18, 2021	$ 0		$ 0	$ 0	$ 0
Beginning Balance, shares at Feb. 18, 2021			0
Issuance of Class B ordinary shares to Sponsor	25,000		$ 750	24,250
Issuance of Class B ordinary shares to Sponsor, shares			7,503,750
Net income (loss)	(10,243)				(10,243)
Balance Ending at Mar. 31, 2021	14,757		$ 750	24,250	(10,243)
Balance Ending, shares at Mar. 31, 2021			7,503,750
Beginning Balance at Feb. 18, 2021	0		$ 0	0	0
Beginning Balance, shares at Feb. 18, 2021			0
Net income (loss)	(10,243)
Balance Ending at Sep. 30, 2021	14,757		$ 750	24,250	(10,243)
Balance Ending, shares at Sep. 30, 2021			7,503,750
Beginning Balance at Jun. 30, 2021	14,757		$ 750	24,250	(10,243)
Beginning Balance, shares at Jun. 30, 2021			7,503,750
Net income (loss)		$ 0
Balance Ending at Sep. 30, 2021	14,757		$ 750	24,250	(10,243)
Balance Ending, shares at Sep. 30, 2021			7,503,750
Beginning Balance at Dec. 31, 2021	(27,132,226)		$ 750	0	(27,132,976)
Beginning Balance, shares at Dec. 31, 2021			7,500,000
Net income (loss)	7,591,476				7,591,476
Balance Ending at Mar. 31, 2022	(19,540,750)		$ 750	0	(19,541,500)
Balance Ending, shares at Mar. 31, 2022			7,500,000
Beginning Balance at Dec. 31, 2021	(27,132,226)		$ 750	0	(27,132,976)
Beginning Balance, shares at Dec. 31, 2021			7,500,000
Net income (loss)	18,062,313	3,612,463
Balance Ending at Sep. 30, 2022	(11,012,214)		$ 750	0	(11,012,964)
Balance Ending, shares at Sep. 30, 2022			7,500,000
Beginning Balance at Mar. 31, 2022	(19,540,750)		$ 750	0	(19,541,500)
Beginning Balance, shares at Mar. 31, 2022			7,500,000
Increase in redemption value of Class A ordinary shares subject to possible redemption	(466,918)				(466,918)
Net income (loss)	7,226,671				7,226,671
Balance Ending at Jun. 30, 2022	(12,780,997)		$ 750	0	(12,781,747)
Balance Ending, shares at Jun. 30, 2022			7,500,000
Increase in redemption value of Class A ordinary shares subject to possible redemption	(1,475,383)				(1,475,383)
Net income (loss)	3,244,166	$ 648,833			3,244,166
Balance Ending at Sep. 30, 2022	$ (11,012,214)		$ 750	$ 0	$ (11,012,964)
Balance Ending, shares at Sep. 30, 2022			7,500,000

UNAUDITED CONDENSED STATEMENT_3

UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended	7 Months Ended	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022
Cash Flows from Operating Activities:
Net income (loss)	$ 3,244,166	$ (10,243)	$ 18,062,313
Adjustments to reconcile net income (loss) to net cash used in operating activities:
General and administrative expenses paid by related party in exchange for issuance of Class B ordinary shares		10,243	0
Income from investments held in Trust Account	(1,475,383)	0	(2,025,609)
Change in fair value of derivative warrant liabilities	(2,120,000)	0	(16,960,000)
Changes in operating assets and liabilities:
Prepaid expenses		0	376,885
Accounts payable		0	187,950
Accounts payable - related party		0	(18,898)
Accrued expenses		0	1,956
Net cash used in operating activities		0	(375,403)
Cash Flows from Financing Activities:
Proceeds from notes payable – related party		46,585	0
Payment of deferred offering costs		(41,585)	0
Net cash flows provided by financing activities		5,000	0
Net change in cash		5,000	(375,403)
Cash - beginning of the period			831,432
Cash - end of the period	$ 456,029	5,000	456,029
Supplemental disclosure of noncash financing activities:
Payment of deferred offering costs by notes payable—related party		104,546	0
Deferred offering costs included in accrued offering costs		$ 101,601	$ 0

Description of Organization and

Description of Organization and Business Operations and Liquidity	9 Months Ended
	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Organization and Business Operations and Liquidity	Note 1 — Description of Organization and Business Operations and Liquidity Ascendant Digital Acquisition Corp. III (the “Company”) was incorporated in the Cayman Islands on February 19, 2021. The Company is a blank check company formed for the purpose of entering into a business combination. The Company is not limited to a particular industry or geographic region for purposes of consummating a business combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. As of September 30, 2022, the Company had not commenced any operations. All activity through September 30, 2022 relates to the Company’s formation and the initial public offering (the “Initial Public Offering”), which is described below and since the offering, the search for a prospective initial Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business combination, at the earliest. The Company generates non-operating The registration statement for the Company’s Initial Public Offering (the “Registration Statement”) was declared effective on November 10, 2021. On November 15, 2021, the Company consummated the sale of 26,100,000 units (“Units”) with respect to the Class A ordinary shares included in the Units being offered (the “Public Shares”) at $10.00 per Unit generating gross proceeds of $261,000,000, which is discussed in Note 3. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 10,330,000 warrants (“Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant in a private placement to the Company’s sponsor, Ascendant Sponsor LP III (the “Sponsor”) generating gross proceeds of $10,330,000. Additionally with the closing of the Initial Public Offering, the Company consummated the closing of the sale of 3,900,000 additional Units upon receiving notice of the underwriter’s election to partially exercise its overallotment option (“Overallotment Units”), generating additional gross proceeds of $39,000,000. Since the underwriters only partially exercised their over-allotment option, on November 15, 2021 the Sponsor forfeited 3,750 shares for no consideration. Simultaneously with the exercise of the overallotment, the Company consummated the Private Placement of an additional 1,170,000 Private Placement Warrants to the Sponsor, generating gross proceeds of $1,170,000. Offering costs for the Initial Public Offering and the exercise of the underwriters’ over-allotment option amounted to $14,172,182, consisting of $3,000,000 of underwriting fees, $10,500,000 of deferred underwriting fees payable (which are held in the Trust Account (defined below)) and $672,182 of other costs. As described in Note 6, the $10,500,000 of deferred underwriting fee payable is contingent upon the consummation of a business combination by February 15, 2023, subject to the terms of the underwriting agreement. Following the closing of the Initial Public Offering and partial exercise of the over-allotment, $306,000,000 ($10.20 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the Private Placement Warrants was placed in a trust account (“Trust Account”) and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 180 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of paragraphs (d)(2), (d)(3) and (d)(4) of Rule 2a-7 of the Investment The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a business combination. There is no assurance that the Company will be able to complete a business combination successfully. The Company must complete one or more initial business combinations having an aggregate fair market value of at least 80% of the assets held in the Trust Account excluding the deferred underwriting commissions and taxes payable on income earned on the Trust Account) at the time of the agreement to enter into the initial business combination. However, the Company will only complete a business combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance the Company will be able to successfully effect a Business Combination. The Company will provide the holders of the outstanding Public Shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially at $10.20 per Public Share, plus any pro rata interest then in the Trust Account, net of taxes payable). There will be no redemption rights with respect to the Company’s warrants. The per-share amount Redemptions of the Company’s Public Shares may be subject to the satisfaction of conditions, including minimum cash conditions, pursuant to an agreement relating to the Company’s business combination. If the Company seeks shareholder approval of the business combination, the Company will proceed with a business combination if a majority of the shares voted are voted in favor of the business combination, or such other vote as required by law or stock exchange rule. If a shareholder vote is not required by applicable law or stock exchange listing requirements and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to its amended and restated memorandum and articles of incorporation (the “Charter”), conduct the redemptions pursuant to the tender offer rules of the SEC and file tender offer documents with the SEC prior to completing a business combination. If, however, shareholder approval of the transaction is required by applicable law or stock exchange listing requirements, or the Company decides to obtain shareholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks shareholder approval in connection with a business combination, the Sponsor agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a business combination. Additionally, each Public Shareholder may elect to redeem their Public Shares without voting, and if they do vote, irrespective of whether they vote for or against the proposed transaction. Notwithstanding the foregoing, the Charter provides that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Class A ordinary shares sold in the Initial Public Offering, without the prior consent of the Company. The Company’s Sponsor, officers, directors and advisory board members (collectively, “Initial Shareholders”) agreed not to propose an amendment to the Charter that would affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a business combination, unless the Company provides the Public Shareholders with the opportunity to redeem their shares of Class A ordinary shares in conjunction with any such amendment. If the Company is unable to complete a business combination by February 15, 2023, 15 months from the closing of the Initial Public Offering (“Combination Period”), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in The Initial Shareholders agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a business combination within the Combination Period. However, if the Initial Shareholders should acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a business combination within the Combination Period. The underwriters agreed to waive their rights to its deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a business combination within the Combination Period, and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.20 per shares held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor agreed to be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account. This liability will not apply with respect to any claims by a third party who executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the Trust Account or to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Going Concern Consideration As of September 30, 2022, the Company had cash of approximately $456,000 and working capital surplus of approximately $0.7 million. The Company’s liquidity needs up prior to the consummation of the Initial Public Offering had been satisfied through the cash receipt of $25,000 from the Sponsor to cover for certain expenses on behalf of the Company in exchange for issuance of Founder Shares (as defined in Note 5), and loan from the related party of approximately $153,396 under the Note (as defined in Note 5). The Company repaid the Note in full on November 11, 2021. Subsequent to the consummation of the Initial Public Offering, the Company’s liquidity has been satisfied through the net proceeds from the consummation of the Initial Public Offering, over-allotment, and the Private Placement held outside of the Trust Account. In addition, in order to finance transaction costs in connection with a business combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (as defined in Note 5). As of September 30, 2022, there were no amounts outstanding under Working Capital Loan. In connection with the Company’s assessment of going concern considerations in accordance with FASB Accounting Standards Update (“ASU”) 2014-15,

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 2 — Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Regulation S-X and The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form 10-K filed Use of Estimates The preparation of unaudited condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements. Making estimates requires management to exercise significant judgment. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Actual results could differ from those estimates. Emerging Growth Company The Company is an emerging growth company as defined in Section 102(b)(1) of the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), which exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but This may make comparison of the Company’s unaudited condensed financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. As of September 30, 2022 and December 31, 2021, the Company had no cash equivalents. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on these accounts, and management believes the Company is not exposed to significant risks on such accounts. Investments Held in the Trust Account The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities are included in interest income from investments held in the Trust Account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC Topic 820, “Fair Value Measurements,” equals or approximates the carrying amounts represented in the condensed balance sheets, primarily due to their short-term nature, except for the derivative warrant liabilities (see Note 9). Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. Derivative Financial Instruments The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end The Warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the carrying value of the instruments to fair value at each reporting period until they are exercised. The determination of the fair value of the warrant liability may be subject to change as more current information becomes available and accordingly the actual results could differ significantly. Derivative warrant liabilities are classified as non-current liabilities as Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480, “Distinguishing Liabilities from Equity.” Shares of Class A ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares sold in the Initial Public Offering and over-allotment feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, as of September 30, 2022 and December 31, 2021, 30,000,000 Class A ordinary shares subject to possible redemption were presented as temporary equity, outside of the shareholders’ deficit section of the Company’s condensed balance sheets. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the Class A ordinary shares subject to possible redemption to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Effective with the closing of the Initial Public Offering (including exercise of the over-allotment option), the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in capital (to As of September 30, 2022 and December 31, 2021, the shares of Class A ordinary condensed Gross proceeds from Initial Public Offering $ 300,000,000 Less: Fair value of Public Warrants at issuance (9,180,180 ) Offering costs allocated to Class A ordinary shares subject to possible redemption (13,723,591 ) Plus: Accretion on Class A ordinary shares subject to possible redemption amount 28,903,771 Class A ordinary share subject to possible redemption—December 31, 2021 306,000,000 Increase in redemption value of Class A ordinary shares subject to redemption 466,918 Class A ordinary shares subject to possible redemption—June 30, 2022 306,466,918 Increase in redemption value of Class A ordinary shares subject to redemption 1,475,383 Class A ordinary shares subject to possible redemption—September 30, 2022 $ 307,942,301 Offering Costs Associated with the Initial Public Offering The Company complies with the requirements of FASB ASC 340-10-S99-1. Offering as non-operating expenses non-current Income Taxes The Company follows the guidance for accounting for income taxes under FASB ASC 740, “Income Taxes.” FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of September 30, 2022 and December 31, 2021. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of September 30, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s unaudited condensed financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. Net Income (Loss) Per Ordinary Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. This presentation assumes a business combination as the most likely outcome. Net income (loss) per ordinary share is calculated by dividing the net loss by the weighted average number of ordinary shares outstanding for the respective period. The calculation of diluted net income (loss) does not consider the effect of the warrants underlying the Units sold in the Initial Public Offering and the Private Placement Warrants to purchase an aggregate of 26,500,000 Class A ordinary shares in the calculation of diluted income (loss) per ordinary share since their exercise is contingent upon future events. As a result, diluted net income (loss) per ordinary share is the same as basic net income (loss) per ordinary share for the three and nine months ended September 30, 2022, for the three months ended September 30, 2021 and for the period from February 19, 2021 (inception) through September 30, 2021. Accretion associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value. The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net loss per ordinary share for each class of ordinary shares: For the Three Months Ended For the Nine Months Ended Class A Class B Class A Class B Basic and diluted net income per ordinary share: Numerator: Allocation of net income $ 2,595,333 $ 648,833 $ 14,449,850 $ 3,612,463 Denominator: Basic and diluted weighted average ordinary shares outstanding 30,000,000 7,500,000 30,000,000 7,500,000 Basic and diluted net income per ordinary share $ 0.09 $ 0.09 $ 0.48 $ 0.48 For the Three Months Ended For the Period From February 19, Class A Class B Class A Class B Basic and diluted net loss per ordinary share: Numerator: Allocation of net loss $ — $ — $ — $ (10,243 ) Denominator: Basic and diluted weighted average ordinary shares outstandin g — 6,525,000 — 6,525,000 Basic and diluted net loss per ordinary share $ — $ — $ — $ (0.00 ) Recent Accounting Pronouncements The Company’s management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying unaudited condensed financial statements.

Initial Public Offering

Initial Public Offering	9 Months Ended
	Sep. 30, 2022
Stockholders' Equity Note [Abstract]
Initial Public Offering	Note 3 — Initial Public Offering On November 15, 2021, the Company consummated its Initial Public Offering of 30,000,000 Units, including 3,900,000 units as a result of the partial exercise by the underwriters of their over-allotment option, at $10.00 per Unit, generating gross proceeds of $300.0 million, and incurring offering costs of approximately $14.2 million, of which approximately $10.5 million was for deferred underwriting commissions. Each Unit consists of one Class A ordinary share, and one-half

Private Placement Warrants

Private Placement Warrants	9 Months Ended
	Sep. 30, 2022
Stockholders' Equity Note [Abstract]
Private Placement Warrants	Note 4 — Private Placement Warrants On November 15, 2021, simultaneously with the consummation of the Initial Public Offering and the underwriters’ partial exercise of their over-allotment option, the Company consummated the issuance and sale (“Private Placement”) of 11,500,000 Private Placement Warrants in a private placement transaction at a price of $10.00 per Placement Unit, generating gross proceeds of $11,500,000. Each whole Private Placement Warrant will be exercisable to purchase one share of Class A ordinary shares at a price of $11.50 per share. A portion of the proceeds from the Private Placement Units will be added to the proceeds from the Proposed Public Offering to be held in the Trust Account. If the Company does not complete a business combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law), and the Private Placement Warrants and all underlying securities will be worthless.

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2022
Related Party Transactions [Abstract]
Related Party Transactions	Note 5 — Related Party Transactions Founder Shares On February 24, 2021, the Sponsor purchased an aggregate of 8,625,000 founder shares for an aggregate purchase price of $25,000, or approximately $0.003 per share. On March 23, 2021, the Sponsor surrendered 1,437,500 founder shares to the Company for cancellation for no consideration creating a total of 7,187,500 founder shares to be outstanding. In March 2021, the Sponsor transferred an aggregate of 230,000 founder shares to members of the Company’s board of directors and the Company’s advisory board, resulting in the Sponsor holding 6,957,500 founder shares. On November 9, 2021, the Company effected a share capitalization of 316,250 founder shares, resulting in the Sponsor holding 7,273,750 founder shares (for an aggregate of 7,503,750 founder shares of which up to 978,750 of which were subject to forfeiture if the underwriters’ over-allotment option is not exercised in full). Since the underwriters only partially exercised their over-allotment option, on November 15, 2021 the Sponsor forfeited 3,750 shares for no consideration. The Founder Shares will automatically convert into shares of Class A ordinary shares at the time of the Company’s initial business combination and are subject to certain transfer restrictions, as described in Note 6. Holders of Founder Shares may also elect to convert their shares of Class B ordinary shares into an equal number of shares of Class A ordinary shares, subject to adjustment, at any time. Related Party Loans On February 24, 2021, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “Note”). This loan was non-interest bearing and payable In addition, in order to finance transaction costs in connection with a business combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a business combination, the Company will repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a business combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a business combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into units of the post business combination entity at a price of $1.00 per warrant. The units would be identical to the Private Placement Units. As of September 30, 2022 and December 31, 2021, there were no Working Capital Loans outstanding. Administrative Services Agreement On November 9, 2021, the Company entered into an agreement with the Sponsor, pursuant to which the Company agreed to pay the Sponsor a total of $10,000 per month for office space, secretarial and administrative services provided to the Company until the earlier of the consummation of a Business Combination or liquidation. The Company incurred $30,000 and $90,000 in connection with such fees during the three and nine months ended September 30, 2022, respectively, included within the general and administrative fees in the accompanying unaudited condensed statements of operations. In addition, the Sponsor, officers and directors, and any of their respective affiliates will be reimbursed for any out-of-pocket expenses Due to Related Party During the period from February 19, 2021 (inception) through December 31, 2021, the Company’s Sponsor paid approximately $19,000 of expenses on behalf of the Company. As of December 31, 2021, outstanding balance for such expenses was approximately $19,000, included in due to related party in current liabilities, on the accompanying condensed balance sheets. Such fees were settled in March 2022.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 6 — Commitments and Contingencies Registration Rights The holders of Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans, if any, will be entitled to registration rights (in the case of the Founder Shares, only after conversion of such shares to shares of Class A ordinary shares) pursuant to a registration rights agreement to be signed on or before the date of the prospectus for the Initial Public Offering. These holders will be entitled to certain demand and “piggyback” registration rights. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until the termination of the applicable lock-up period for the Underwriting Agreement The Company granted the underwriters a 45-day option The underwriters were paid a cash underwriting discount of $0.10 per unit on the offering not including the Units issued with the underwriter’s exercise of their over-allotment option, or $3,000,000 in the aggregate at the closing of the Initial Public Offering. In addition, the underwriters are entitled to a deferred underwriting commissions of $0.35 per unit, or $10,500,000 from the closing of the Initial Public Offering. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely if the Company completes a business combination, subject to the terms of the underwriting agreement. Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic and has In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy are not determinable as of the date of these financial statements and the specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these unaudited condensed financial statements.

Class A Ordinary Shares Subject

Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit	9 Months Ended
	Sep. 30, 2022
Temporary Equity And Stockholders Equity Note [Abstract]
Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit	Note 7 — Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit Preference Shares Class A Ordinary Shares — Class B Ordinary Shares — Shareholders of the ordinary shares of record are entitled to one vote The shares of Class B ordinary shares will automatically convert into shares of Class A ordinary shares at the time of the initial business combination on a one-for-one basis, subject to an as-converted basis,

Warrants

Warrants	9 Months Ended
	Sep. 30, 2022
Warrants and Rights Note Disclosure [Abstract]
Warrants	Note 8 — Warrants As of September 30, 2022 and December 31, 2021, the Company has 15,000,000 Public Warrants and 11,500,000 Private Placement Warrants outstanding. Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable on the later of (a) the completion of a business combination and (b) 12 months from the closing of the Proposed Public Offering. The Public Warrants will expire five years from the completion of a business combination or earlier upon redemption or liquidation. The Company will not be obligated to deliver any shares of ordinary shares pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the ordinary shares underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption is available. Redemption of warrants when the price per Class A ordinary shares equals or exceeds $18.00: Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants): • in whole and not in part; • at a price of $0.01 per warrant; • upon a minimum of 30 days’ prior written notice of redemption, which the Company refers to as the “30-day • if, and only if, the last reported sale price (the “closing price”) of Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “Description of Securities—Warrants— Public Shareholders’ Warrants—Anti-Dilution Adjustments”) for any 20 trading days within a 30-trading day The Company will not redeem the warrants as described above unless an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the warrants is effective and a current prospectus relating to those Class A ordinary shares is available throughout the 30-day redemption Except as set forth below, none of the private placement warrants will be redeemable by the Company so long as they are held by the Company’s sponsor or its permitted transferees. Redemption of warrants when the price per Class A ordinary shares equals or exceeds $10.00: • in whole and not in part; • at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the table set forth under “Description of Securities— Warrants—Public Shareholders’ Warrants” based on the redemption date and the “fair market value” of Class A ordinary shares (as defined below) except as otherwise described in “Description of Securities—Warrants—Public Shareholders’ Warrants”; • if, and only if, the closing price of Class A ordinary shares equals or exceeds $10.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “Description of Securities—Warrants—Public Shareholders’ Warrants—Anti-dilution Adjustments”) for any 20 trading days within the 30-trading day period • if the closing price of the Class A ordinary shares for any 20 trading days within a 30-trading day The “fair market value” of Class A ordinary shares for the above purpose shall mean the volume weighted average price of Class A ordinary shares during the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of warrants. The Company will provide warrant holders with the final fair market value no later than one business day after the 10 trading day period described above ends. In no event will the warrants be exercisable in connection with this redemption feature for more than 0.361 Class A ordinary shares per warrant (subject to adjustment). Any redemption of the warrants for Class A ordinary shares will apply to both the public warrants and the Private Placement Warrants. No fractional Class A ordinary shares will be issued upon redemption. If, upon redemption, a holder would be entitled to receive a fractional interest in a share, the Company will round down to the nearest whole number of the number of Class A ordinary shares to be issued to the holder. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis”. The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the shares of ordinary shares issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable for cash or on a cashless basis, at the holder’s option, and be non-redeemable so long as The exercise price and number of ordinary shares issuable on exercise of the warrants may be adjusted in certain circumstances including in the event of a share dividend, extraordinary dividend or the Company’s recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuances of shares of ordinary shares at a price below their respective exercise prices. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. In addition, if the Company issues additional ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per share of ordinary shares (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors, and in the case of any such issuance to the Initial Shareholders or their affiliates, without taking into account any Founder Shares held by them prior to such issuance), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of (i) the Market Value or (ii) the price at which the Company issues the additional shares of ordinary shares or equity-linked securities.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Sep. 30, 2022
Fair Value Disclosures [Abstract]
Fair Value Disclosures [Text Block]	Note 9 — Fair Value Measurements The following tables present information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of September 30, 2022 and December 31, 2021 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value. As of September 30, 2022 Fair Value Measured as of September 30, 2022 Description Quoted Prices in Active Markets (Level 1) Significant Other (Level 2) Significant Other (Level 3) Assets: Investments held in Trust Account (1) $ 308,042,301 $ — $ — Liabilities: Derivative warrant liabilities - Public Warrant $ 750,000 $ — $ — Derivative warrant liabilities - Private Placement Warrant $ — $ — $ 575,000 As of December 31, 2021 Description Quoted Prices in Active Markets (Level 1) Significant Other Observable Inputs (Level 2) Significant Other Unobservable Inputs (Level 3) Assets: Investments held in Trust Account (1) $ 306,016,692 $ — $ — Liabilities: Derivative warrant liabilities—Public warrant $ — $ — $ 10,350,000 Derivative warrant liabilities—Private warrant $ — $ — $ 7,935,000 (1) Includes $1,536 and $933 in cash as of September 30, 2022 and December 31, 2021, respectively. Transfers to/from Levels 1, 2, and 3 are recognized at the beginning of the reporting period. The estimated fair value of the Public Warrants transferred from a Level 3 measurement to a Level 1 fair value measurement in January 2022, as the Public Warrants were separately listed and traded in in January 2022. Level 1 assets include investments in money market funds that invest solely in U.S. government securities and U.S. Treasury Bills. The Company uses inputs such as actual trade data, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments. The Company utilizes a Monte Carlo simulation model to value the Private Placement Warrants and the Public Warrants prior to being separately listed and traded, with changes in fair value recognized in the accompanying unaudited condensed statements of operations. The estimated fair value of the warrant liability is determined using Level 3 inputs. Inherent in a Monte Carlo simulation are assumptions related to expected share-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its ordinary shares based on historical volatility that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve For the three months ended September 30, 2022 and 2021, the Company recognized a change to the statement of operations resulting from a decrease (increase) in the fair value of liabilities of approximately $2.1 million and $0, respectively, presented as change in fair value of derivative warrant liabilities on the accompanying statement of operations. For the nine months ended September 30, 2022 and for the period from February 19, 2021 (inception) through September 30, 2021, the Company recognized a change to the statement of operations resulting from a decrease (increase) in the fair value of liabilities of approximately $17.0 million and $0, respectively, presented as change in fair value of derivative warrant liabilities on the accompanying statement of operations. The following table provides quantitative information regarding Level 3 fair value measurements inputs as of September 30, 2022 and December 31, 2021: September 30, 2022 December 31, 2021 Exercise price $ 11.50 $ 11.50 Volatility 9.70 % 10.80 % Stock price $ 10.14 $ 9.81 Expected term (years) 5.25 5.86 Risk-free rate 3.97 % 1.33 % Dividend yield 0.00 % 0.00 % Probability of business combination 4.00 % 90.00 % The change in the fair value of the Level 3 warrant liabilities for the three and nine months ended September 30, 2022 is summarized as follow: Derivative warrant liabilities at December 31, 2021 - Level 3 $ 18,285,000 Transfer of Public Warrants from Level 3 to level 1 (10,350,000 ) Change in fair value of derivative warrant liabilities (3,335,000 ) Derivative warrant liabilities at March 31, 2022 - Level 3 4,600,000 Change in fair value of derivative warrant liabilities (3,105,000 ) Derivative warrant liabilities at June 30, 2022 - Level 3 1,495,000 Change in fair value of derivative warrant liabilities (920,000 ) Derivative warrant liabilities at September 30, 2022 - Level 3 $ 575,000

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2022
Subsequent Events [Abstract]
Subsequent Events	Note 10 — Subsequent Events The Company evaluated subsequent events and transactions that occurred after the condensed balance sheet date up to the date that the unaudited condensed financial statements were issued. Based on this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Regulation S-X and The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form 10-K filed
Use of Estimates	Use of Estimates The preparation of unaudited condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements. Making estimates requires management to exercise significant judgment. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Actual results could differ from those estimates.
Emerging Growth Company	Emerging Growth Company The Company is an emerging growth company as defined in Section 102(b)(1) of the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), which exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but This may make comparison of the Company’s unaudited condensed financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. As of September 30, 2022 and December 31, 2021, the Company had no cash equivalents.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on these accounts, and management believes the Company is not exposed to significant risks on such accounts.
Investments Held in the Trust Account	Investments Held in the Trust Account The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities are included in interest income from investments held in the Trust Account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC Topic 820, “Fair Value Measurements,” equals or approximates the carrying amounts represented in the condensed balance sheets, primarily due to their short-term nature, except for the derivative warrant liabilities (see Note 9).
Fair Value Measurements	Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
Derivative Financial Instruments	Derivative Financial Instruments The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end The Warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the carrying value of the instruments to fair value at each reporting period until they are exercised. The determination of the fair value of the warrant liability may be subject to change as more current information becomes available and accordingly the actual results could differ significantly. Derivative warrant liabilities are classified as non-current liabilities as
Class A Ordinary shares subject to Possible Redemption	Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480, “Distinguishing Liabilities from Equity.” Shares of Class A ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares sold in the Initial Public Offering and over-allotment feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, as of September 30, 2022 and December 31, 2021, 30,000,000 Class A ordinary shares subject to possible redemption were presented as temporary equity, outside of the shareholders’ deficit section of the Company’s condensed balance sheets. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the Class A ordinary shares subject to possible redemption to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Effective with the closing of the Initial Public Offering (including exercise of the over-allotment option), the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in capital (to As of September 30, 2022 and December 31, 2021, the shares of Class A ordinary condensed Gross proceeds from Initial Public Offering $ 300,000,000 Less: Fair value of Public Warrants at issuance (9,180,180 ) Offering costs allocated to Class A ordinary shares subject to possible redemption (13,723,591 ) Plus: Accretion on Class A ordinary shares subject to possible redemption amount 28,903,771 Class A ordinary share subject to possible redemption—December 31, 2021 306,000,000 Increase in redemption value of Class A ordinary shares subject to redemption 466,918 Class A ordinary shares subject to possible redemption—June 30, 2022 306,466,918 Increase in redemption value of Class A ordinary shares subject to redemption 1,475,383 Class A ordinary shares subject to possible redemption—September 30, 2022 $ 307,942,301
Offering Costs Associated with the Initial Public Offering	Offering Costs Associated with the Initial Public Offering The Company complies with the requirements of FASB ASC 340-10-S99-1. Offering as non-operating expenses non-current
Income Taxes	Income Taxes The Company follows the guidance for accounting for income taxes under FASB ASC 740, “Income Taxes.” FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of September 30, 2022 and December 31, 2021. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of September 30, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s unaudited condensed financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Net Income (Loss) Per Ordinary Share	Net Income (Loss) Per Ordinary Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. This presentation assumes a business combination as the most likely outcome. Net income (loss) per ordinary share is calculated by dividing the net loss by the weighted average number of ordinary shares outstanding for the respective period. The calculation of diluted net income (loss) does not consider the effect of the warrants underlying the Units sold in the Initial Public Offering and the Private Placement Warrants to purchase an aggregate of 26,500,000 Class A ordinary shares in the calculation of diluted income (loss) per ordinary share since their exercise is contingent upon future events. As a result, diluted net income (loss) per ordinary share is the same as basic net income (loss) per ordinary share for the three and nine months ended September 30, 2022, for the three months ended September 30, 2021 and for the period from February 19, 2021 (inception) through September 30, 2021. Accretion associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value. The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net loss per ordinary share for each class of ordinary shares: For the Three Months Ended For the Nine Months Ended Class A Class B Class A Class B Basic and diluted net income per ordinary share: Numerator: Allocation of net income $ 2,595,333 $ 648,833 $ 14,449,850 $ 3,612,463 Denominator: Basic and diluted weighted average ordinary shares outstanding 30,000,000 7,500,000 30,000,000 7,500,000 Basic and diluted net income per ordinary share $ 0.09 $ 0.09 $ 0.48 $ 0.48 For the Three Months Ended For the Period From February 19, Class A Class B Class A Class B Basic and diluted net loss per ordinary share: Numerator: Allocation of net loss $ — $ — $ — $ (10,243 ) Denominator: Basic and diluted weighted average ordinary shares outstandin g — 6,525,000 — 6,525,000 Basic and diluted net loss per ordinary share $ — $ — $ — $ (0.00 )
Recent Accounting Pronouncements	Recent Accounting Pronouncements The Company’s management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying unaudited condensed financial statements.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2022
Temporary Equity Disclosure [Abstract]
Summary Of Reconciled Balance Sheet Class A Ordinary Shares	As of September 30, 2022 and December 31, 2021, the shares of Class A ordinary condensed Gross proceeds from Initial Public Offering $ 300,000,000 Less: Fair value of Public Warrants at issuance (9,180,180 ) Offering costs allocated to Class A ordinary shares subject to possible redemption (13,723,591 ) Plus: Accretion on Class A ordinary shares subject to possible redemption amount 28,903,771 Class A ordinary share subject to possible redemption—December 31, 2021 306,000,000 Increase in redemption value of Class A ordinary shares subject to redemption 466,918 Class A ordinary shares subject to possible redemption—June 30, 2022 306,466,918 Increase in redemption value of Class A ordinary shares subject to redemption 1,475,383 Class A ordinary shares subject to possible redemption—September 30, 2022 $ 307,942,301
Summary Of Basic and Diluted Net Loss Per Share	The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net loss per ordinary share for each class of ordinary shares: For the Three Months Ended For the Nine Months Ended Class A Class B Class A Class B Basic and diluted net income per ordinary share: Numerator: Allocation of net income $ 2,595,333 $ 648,833 $ 14,449,850 $ 3,612,463 Denominator: Basic and diluted weighted average ordinary shares outstanding 30,000,000 7,500,000 30,000,000 7,500,000 Basic and diluted net income per ordinary share $ 0.09 $ 0.09 $ 0.48 $ 0.48 For the Three Months Ended For the Period From February 19, Class A Class B Class A Class B Basic and diluted net loss per ordinary share: Numerator: Allocation of net loss $ — $ — $ — $ (10,243 ) Denominator: Basic and diluted weighted average ordinary shares outstandin g — 6,525,000 — 6,525,000 Basic and diluted net loss per ordinary share $ — $ — $ — $ (0.00 )

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2022
Fair Value Disclosures [Abstract]
Summary of Fair Value Assets and Liabilities Measured on Recurring Basis	The following tables present information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of September 30, 2022 and December 31, 2021 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value. As of September 30, 2022 Fair Value Measured as of September 30, 2022 Description Quoted Prices in Active Markets (Level 1) Significant Other (Level 2) Significant Other (Level 3) Assets: Investments held in Trust Account (1) $ 308,042,301 $ — $ — Liabilities: Derivative warrant liabilities - Public Warrant $ 750,000 $ — $ — Derivative warrant liabilities - Private Placement Warrant $ — $ — $ 575,000 As of December 31, 2021 Description Quoted Prices in Active Markets (Level 1) Significant Other Observable Inputs (Level 2) Significant Other Unobservable Inputs (Level 3) Assets: Investments held in Trust Account (1) $ 306,016,692 $ — $ — Liabilities: Derivative warrant liabilities—Public warrant $ — $ — $ 10,350,000 Derivative warrant liabilities—Private warrant $ — $ — $ 7,935,000 (1) Includes $1,536 and $933 in cash as of September 30, 2022 and December 31, 2021, respectively.
Summary of Quantitative Information Regarding Level 3 Fair Value Measurements	The following table provides quantitative information regarding Level 3 fair value measurements inputs as of September 30, 2022 and December 31, 2021: September 30, 2022 December 31, 2021 Exercise price $ 11.50 $ 11.50 Volatility 9.70 % 10.80 % Stock price $ 10.14 $ 9.81 Expected term (years) 5.25 5.86 Risk-free rate 3.97 % 1.33 % Dividend yield 0.00 % 0.00 % Probability of business combination 4.00 % 90.00 %
Summary of Fair Value of the Level 3 Warrant Liabilities	The change in the fair value of the Level 3 warrant liabilities for the three and nine months ended September 30, 2022 is summarized as follow: Derivative warrant liabilities at December 31, 2021 - Level 3 $ 18,285,000 Transfer of Public Warrants from Level 3 to level 1 (10,350,000 ) Change in fair value of derivative warrant liabilities (3,335,000 ) Derivative warrant liabilities at March 31, 2022 - Level 3 4,600,000 Change in fair value of derivative warrant liabilities (3,105,000 ) Derivative warrant liabilities at June 30, 2022 - Level 3 1,495,000 Change in fair value of derivative warrant liabilities (920,000 ) Derivative warrant liabilities at September 30, 2022 - Level 3 $ 575,000

Description of Organization a_2

Description of Organization and Business Operations and Liquidity - Additional Information (Detail) - USD ($)			1 Months Ended	7 Months Ended	9 Months Ended	10 Months Ended
	Nov. 15, 2021	Nov. 09, 2021	Mar. 31, 2021	Sep. 30, 2021	Sep. 30, 2022	Dec. 31, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Proceeds from issuance initial public offering	$ 300,000,000
Stock issued during period, value, new issues			$ 25,000
Offering costs				$ 41,585	$ 0
Sale of stock, price per share					$ 10.2
Restricted Investments Term					180 days
Percentage of public shares to be redeemed on non completion of business combination					100%
Dissolution expense					$ 100,000
Minimum share price of the residual assets remaining available for distribution					$ 10.2
Cash					$ 456,029	$ 831,432
Net Working Capital					700,000
Due To Related Parties, Current						19,000
Working Capital Loan [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Due To Related Parties, Current					0	0
Founder Shares [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Shares issued, shares, share-based payment arrangement, forfeited		978,750
Sponsor [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Repayments of Related Party Debt					153,396
Sponsor [Member] | Founder Shares [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Stock issued during period, value, new issues					$ 25,000
Shares issued, shares, share-based payment arrangement, forfeited	3,750
Minimum [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Percentage of fair market value of target business to asset held in trust account					80%
Percentage of redeeming shares of public shares without the companies prior written consent					15%
Minimum [Member] | Post Transaction [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Percentage of voting interests acquired					50%
Private Placement Warrants [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Class of warrants and rights issued during the period	11,500,000
Class of warrants and rights issued, price per warrant	$ 10
Proceeds from issuance of private placement	$ 11,500,000
IPO [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Stock issued during period, shares, new issues	30,000,000
Share price	$ 10
Offering costs					$ 14,172,182
Underwriting expense paid | $					3,000,000
Deferred underwriting fees payable					10,500,000
Other offering costs					672,182
Payments to acquire restricted investments					$ 306,000,000
IPO [Member] | Private Placement Warrants [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Class of warrants and rights issued during the period	10,330,000
Class of warrants and rights issued, price per warrant	$ 1
Proceeds from issuance of private placement	$ 10,330,000
Over-Allotment Option [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Stock issued during period, shares, new issues	3,900,000
Stock issued during period, value, new issues	$ 39,000,000
Shares issued, shares, share-based payment arrangement, forfeited	3,750
Over-Allotment Option [Member] | Private Placement Warrants [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Class of warrants and rights issued during the period	1,170,000
Proceeds from issuance of private placement	$ 1,170,000
Common Class A [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Proceeds from issuance initial public offering						$ 300,000,000
Common Class A [Member] | IPO [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Stock issued during period, shares, new issues	26,100,000
Share price	$ 10
Proceeds from issuance initial public offering	$ 261,000,000
Public Shares [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Share price					$ 10.2

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($)	9 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Cash equivalents	$ 0	$ 0
FDIC Insured Amount	250,000
Unrecognized tax benefits	0
Accrued for interest and penalties	$ 0
Term of Restricted Investments	185 days
Common Class A [Member]
Temporary Equity, Shares Issued	30,000,000	30,000,000
Common Class A [Member] | Initial Public Offer And Private Placement [Member]
Antidilutive securities excluded from computation of earnings per share, amount	26,500,000

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Summary Of Reconciled Balance Sheet Class A Ordinary Shares (Detail) - USD ($)		3 Months Ended	6 Months Ended	10 Months Ended
	Nov. 15, 2021	Sep. 30, 2022	Jun. 30, 2022	Dec. 31, 2021
Redeemable Noncontrolling Interest [Line Items]
Gross proceeds from Initial Public Offering	$ 300,000,000
Class A ordinary share subject to possible redemption		$ 307,942,301		$ 306,000,000
Common Class A [Member]
Redeemable Noncontrolling Interest [Line Items]
Gross proceeds from Initial Public Offering				300,000,000
Fair value of Public Warrants at issuance				(9,180,180)
Offering costs allocated to Class A ordinary shares subject to possible redemption				(13,723,591)
Accretion on Class A ordinary shares subject to possible redemption amount				28,903,771
Increase in redemption value of Class A ordinary shares subject to redemption		1,475,383	$ 466,918
Class A ordinary share subject to possible redemption		$ 307,942,301	$ 306,466,918	$ 306,000,000

Summary of Significant Accoun_6

Summary of Significant Accounting Policies - Summary Of Basic and Diluted Net Loss Per Share (Details) - USD ($)	1 Months Ended	3 Months Ended				7 Months Ended	9 Months Ended
	Mar. 31, 2021	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2021	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Numerator:
Allocation of net income (loss)	$ (10,243)	$ 3,244,166	$ 7,226,671	$ 7,591,476		$ (10,243)	$ 18,062,313
Common Class A [Member]
Numerator:
Allocation of net income (loss)		$ 2,595,333			$ 0		$ 14,449,850	$ 0
Denominator:
Basic weighted average shares outstanding		30,000,000			0	0	30,000,000
Diluted weighted average shares outstanding		30,000,000			0		30,000,000	0
Basic net income (loss) per ordinary share		$ 0.09			$ 0	$ 0	$ 0.48
Diluted net income (loss) per ordinary share		$ 0.09			$ 0		$ 0.48	$ 0
Common Class B [Member]
Numerator:
Allocation of net income (loss)		$ 648,833			$ 0		$ 3,612,463	$ (10,243)
Denominator:
Basic weighted average shares outstanding		7,500,000			6,525,000	6,525,000	7,500,000
Diluted weighted average shares outstanding		7,500,000			6,525,000	6,525,000	7,500,000	6,525,000
Basic net income (loss) per ordinary share		$ 0.09			$ 0	$ 0	$ 0.48
Diluted net income (loss) per ordinary share		$ 0.09			$ 0	$ 0	$ 0.48	$ 0

Initial Public Offering - Addit

Initial Public Offering - Additional Information (Detail) - USD ($)		10 Months Ended
	Nov. 15, 2021	Dec. 31, 2021	Sep. 30, 2022
Class of Stock [Line Items]
Proceeds from issuance initial public offering	$ 300,000,000
Deferred underwriting commissions		$ 10,500,000	$ 10,500,000
Public Warrants [Member]
Class of Stock [Line Items]
Exercise price of warrant	$ 11.5
warrants issuable	1
Common Class A [Member]
Class of Stock [Line Items]
Stock conversion basis	one-half of one redeemable warrant
Shares issued	1
Proceeds from issuance initial public offering		$ 300,000,000
IPO [Member]
Class of Stock [Line Items]
Stock issued during period, shares, new issues	30,000,000
Share price	$ 10
IPO [Member] | Common Class A [Member]
Class of Stock [Line Items]
Stock issued during period, shares, new issues	26,100,000
Share price	$ 10
Proceeds from issuance initial public offering	$ 261,000,000
Over-Allotment Option [Member]
Class of Stock [Line Items]
Stock issued during period, shares, new issues	3,900,000
Expense Related to Distribution or Servicing and Underwriting Fees	$ 14,200,000
Deferred underwriting commissions	$ 10,500,000

Private Placement Warrants - Ad

Private Placement Warrants - Additional Information (Detail) - Private Placement Warrants [Member]	Nov. 15, 2021 USD ($) $ / shares shares
Class of Stock [Line Items]
Class of warrants and rights issued during the period | shares	11,500,000
Class of warrants and rights issued, price per warrant	$ 10
Proceeds from issuance of private placement | $	$ 11,500,000
Exercise price of warrant	$ 11.5

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Detail) - USD ($)						1 Months Ended	3 Months Ended	9 Months Ended	10 Months Ended
	Nov. 15, 2021	Nov. 09, 2021	Mar. 31, 2021	Mar. 23, 2021	Feb. 24, 2021	Mar. 31, 2021	Sep. 30, 2022	Sep. 30, 2022	Dec. 31, 2021
Related Party Transaction [Line Items]
Stock issued during period, value, new issues						$ 25,000
Due to Related Parties Current									$ 19,000
Related Party Transaction, Expenses from Transactions with Related Party									19,000
Working Capital Loan [Member]
Related Party Transaction [Line Items]
Debt Instrument Convertible Into Warrants							$ 1,500,000	$ 1,500,000
Debt Instrument Conversion Price							$ 1	$ 1
Due to Related Parties Current							$ 0	$ 0	$ 0
Administrative Services [Member]
Related Party Transaction [Line Items]
RelatedPartyTransaction, SellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty							$ 30,000	$ 90,000
Sponsor [Member] | Office Space, Administrative and Support Services [Member]
Related Party Transaction [Line Items]
Related Party Transaction, Amounts of Transaction		$ 10,000
Sponsor [Member] | Promissory Note [Member] | Related Party Loans [Member]
Related Party Transaction [Line Items]
Debt Instrument, Face Amount					$ 300,000
Debt Instrument Interest Rate							0%	0%
Founder Shares [Member]
Related Party Transaction [Line Items]
Number of shares forfeited during the period.		978,750
Capitalization of Shares		316,250
Founder Shares [Member] | Sponsor [Member]
Related Party Transaction [Line Items]
Stock issued during period, value, new issues								$ 25,000
Number of shares forfeited during the period.	3,750
Founder Shares [Member] | Sponsor [Member] | Director [Member]
Related Party Transaction [Line Items]
Stock issued during period, shares, new issues			230,000
Number of shares forfeited during the period.			6,957,500
Common Class B [Member] | Founder Shares [Member] | Sponsor [Member]
Related Party Transaction [Line Items]
Stock issued during period, shares, new issues					8,625,000
Stock issued during period, value, new issues					$ 25,000
Stock Issued During Period, Shares, Other				1,437,500
Temporary equity shares outstanding				7,187,500
Minimum [Member] | Sponsor [Member]
Related Party Transaction [Line Items]
Temporary equity shares outstanding		7,273,750
Maximum [Member] | Founder Shares [Member]
Related Party Transaction [Line Items]
Temporary equity shares outstanding		7,503,750
Maximum [Member] | Common Class B [Member] | Founder Shares [Member] | Sponsor [Member]
Related Party Transaction [Line Items]
Shares Issued, Price Per Share					$ 0.003

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail) - USD ($)		9 Months Ended
	Nov. 15, 2021	Sep. 30, 2022
Other Commitments [Line Items]
Aggregate Cash Underwriting Discount	$ 3,000,000
Deferred Underwriting Commissions	$ 10,500,000
Over-Allotment Option [Member]
Other Commitments [Line Items]
Stock Issued During Period, Shares, New Issues	3,900,000
Over-Allotment Option [Member] | Underwriting Agreement [Member]
Other Commitments [Line Items]
Number Of Days Granted For Exercising The Option		45 days
Common Stock, Shares Subscribed but Unissued		3,915,000
Stock Issued During Period, Shares, New Issues	3,900,000
Stock Forfeited During The Period Shares	15,000
IPO [Member]
Other Commitments [Line Items]
Stock Issued During Period, Shares, New Issues	30,000,000
IPO [Member] | Underwriting Agreement [Member]
Other Commitments [Line Items]
Cash Underwriting Discount Per Unit	$ 0.1
Deferred Underwriting Commissions Per Unit	$ 0.35

Class A Ordinary Shares Subje_2

Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit - Additional Information (Detail) - $ / shares		9 Months Ended
	Nov. 15, 2021	Sep. 30, 2022	Dec. 31, 2021
Class of Stock [Line Items]
Preferred stock par or stated value per share		$ 0.0001	$ 0.0001
Preferred stock shares authorized		5,000,000	5,000,000
Preferred stock shares issued		0	0
Preferred stock shares outstanding		0	0
Common Class A [Member]
Class of Stock [Line Items]
Common stock par or stated value per share		$ 0.0001	$ 0.0001
Common stock shares authorized		500,000,000	500,000,000
Common stock shares outstanding		0	0
Common Stock, Conversion Basis	one-half of one redeemable warrant
Common Class A [Member] | Common Stock [Member]
Class of Stock [Line Items]
Common stock shares outstanding		30,000,000	30,000,000
Common Class B [Member]
Class of Stock [Line Items]
Common stock par or stated value per share		$ 0.0001	$ 0.0001
Common stock shares authorized		50,000,000	50,000,000
Common stock shares outstanding		7,500,000	7,500,000
Common stock shares voting rights		one vote
Common Class B [Member] | Common Stock [Member]
Class of Stock [Line Items]
Common stock shares outstanding		7,500,000	7,500,000
Common Class B [Member] | Conversion of Class B to Class A Common Stock [Member]
Class of Stock [Line Items]
Common Stock, Conversion Basis		one-for-one
Percentage Of Common Stock Issued And Outstanding		26%

Warrants - Additional Informati

Warrants - Additional Information (Detail) - $ / shares	9 Months Ended	10 Months Ended
	Sep. 30, 2022	Dec. 31, 2021	Nov. 15, 2021
Redemption of Warrants [Member] | Common Class A [Member]
Class of Warrant or Right [Line Items]
Trading day period to calculate volume weighted average trading price following notice of redemption	10 days	10 days
Number of shares issued upon exercise of warrant	0.361
Public Warrants [Member]
Class of Warrant or Right [Line Items]
Class of warrant or right, outstanding	15,000,000	15,000,000
Period to exercise warrants after closing of proposed public offering	12 months
Warrants and rights outstanding term	5 years
Number of shares issued upon exercise of warrant			1
Public Warrants [Member] | Common Class A [Member]
Class of Warrant or Right [Line Items]
Threshold trading days	20 days
Threshold issue price for capital raising purpose in connection with closing of business combination	$ 9.2
Percentage of gross proceeds on total equity proceeds	60%
Volume weighted average price per share	$ 9.2
Adjusted exercise price of warrants percentage	115%
Public Warrants [Member] | Redemption Of Warrants When Class A Equals or Exceeds Eighteen Dollars [Member]
Class of Warrant or Right [Line Items]
Notice period to redeem warrants	30 days
Warrant redemption price (in dollars per share)	$ 0.01
Public Warrants [Member] | Redemption Of Warrants When Class A Equals or Exceeds Eighteen Dollars [Member] | Common Class A [Member]
Class of Warrant or Right [Line Items]
Share price (in dollars per share)	$ 18
Threshold trading days	20 days
Threshold consecutive trading days	30 days
Public Warrants [Member] | Redemption Of Warrants When Class A Equals or Exceeds Ten Dollars [Member]
Class of Warrant or Right [Line Items]
Notice period to redeem warrants	30 days
Warrant redemption price (in dollars per share)	$ 0.1
Public Warrants [Member] | Redemption Of Warrants When Class A Equals or Exceeds Ten Dollars [Member] | Common Class A [Member]
Class of Warrant or Right [Line Items]
Share price (in dollars per share)	$ 10
Threshold trading days	20 days
Threshold consecutive trading days	30 days
Private Placement Warrants [Member]
Class of Warrant or Right [Line Items]
Class of warrant or right, outstanding	11,500,000	11,500,000
Private Placement Warrants [Member] | Redemption Of Warrants When Class A Equals or Exceeds Ten Dollars [Member] | Common Class A [Member]
Class of Warrant or Right [Line Items]
Share price (in dollars per share)	$ 18
Threshold trading days	20 days
Threshold consecutive trading days	30 days

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Detail) - USD ($)	3 Months Ended		7 Months Ended	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2021	Sep. 30, 2022	Dec. 31, 2021
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Adjustment to fair value of warrants	$ 2,120,000	$ 0	$ 0	$ 16,960,000
Cash [Member] | Level 1 [Member] | Fair Value Measurements Recurring [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, Fair Value Disclosure	$ 1,536			$ 1,536	$ 933

Fair Value Measurements - Summa

Fair Value Measurements - Summary of Fair Value Assets and Liabilities Measured on Recurring Basis (Details) - Fair Value Measurements Recurring [Member] - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Level 1 [Member]
Assets:
Investments held in Trust Account	$ 308,042,301	$ 306,016,692
Level 1 [Member] | Warrant Liabilities [Member] | Public Warrants [Member]
Liabilities:
Derivative warrant liabilities	750,000	0
Level 1 [Member] | Warrant Liabilities [Member] | Private warrant [Member]
Liabilities:
Derivative warrant liabilities	0	0
Level 2 [Member]
Assets:
Investments held in Trust Account	0	0
Level 2 [Member] | Warrant Liabilities [Member] | Public Warrants [Member]
Liabilities:
Derivative warrant liabilities	0	0
Level 2 [Member] | Warrant Liabilities [Member] | Private warrant [Member]
Liabilities:
Derivative warrant liabilities	0	0
Level 3 [Member]
Assets:
Investments held in Trust Account	0	0
Level 3 [Member] | Warrant Liabilities [Member] | Public Warrants [Member]
Liabilities:
Derivative warrant liabilities	0	10,350,000
Level 3 [Member] | Warrant Liabilities [Member] | Private warrant [Member]
Liabilities:
Derivative warrant liabilities	$ 575,000	$ 7,935,000

Fair Value Measurements - Sum_2

Fair Value Measurements - Summary of Quantitative Information Regarding Level 3 Fair Value Measurements (Details) - Fair Value, Inputs, Level 3 [Member]	9 Months Ended	10 Months Ended
	Sep. 30, 2022 $ / shares	Dec. 31, 2021 $ / shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price	$ 11.5	$ 11.5
Volatility	9.70%	10.80%
Stock price	$ 10.14	$ 9.81
Expected team	5 years 3 months	5 years 10 months 9 days
Risk-free rate	3.97%	1.33%
Dividend yield	0%	0%
Probability of business combination	4	90

Fair Value Measurements - Sum_3

Fair Value Measurements - Summary of Fair Value of the Level 3 Warrant Liabilities (Detail) - USD ($)	3 Months Ended				7 Months Ended	9 Months Ended
	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2021	Sep. 30, 2021	Sep. 30, 2022
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]
Beginning Balance			$ 18,285,000			$ 18,285,000
Change in fair value of derivative warrant liabilities	$ (2,120,000)			$ 0	$ 0	(16,960,000)
Ending balance	1,325,000					1,325,000
Fair Value, Inputs, Level 3 [Member]
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]
Beginning Balance	1,495,000	$ 4,600,000	18,285,000			18,285,000
Transfer of Public Warrants			(10,350,000)
Change in fair value of derivative warrant liabilities	(920,000)	(3,105,000)	(3,335,000)
Ending balance	$ 575,000	$ 1,495,000	$ 4,600,000			$ 575,000